Literature DB >> 26944915

Quality of Life in Adults with Neurofibromatosis 1 in Brazil.

Natália Parenti Bicudo1, Balduíno Ferreira de Menezes Neto1, Lucimar Retto da Silva de Avó1, Carla Maria Ramos Germano1, Débora Gusmão Melo2,3.   

Abstract

Neurofibromatosis type 1 (NF1) is a neurocutaneous genetic disorder that can be associated with severe complications, and it may shorten patients' lifespan and affect their quality of life negatively. This study aimed to examine quality of life constructs among adults with NF1 in Brazil. It is an exploratory, descriptive and cross-sectional study consisting of two stages, involving thirteen adult patients with NF1. The first stage was developed using a quantitative methodology, namely the WHOQOL-100 questionnaire; responses for the 13 patients were compared to a matched control group. The second stage comprised clinical-qualitative research whereby participants took part in a semi-structured interview; these data were analyzed using the categorical thematic analysis technique. There were no statistically significant differences in the questionnaire domains between the NF1 patients and the control subjects. Eighteen main themes were extracted from the interviews, showing interference of the NF1 visibility principally in psychological aspects and social relationships. Patients mentioned curiosity about NF1 and confusion about the distinctions between NF1 and contagious diseases, which lead to prejudice. They were concerned about the future and how the disease would develop in themselves and their offspring, and emphasized difficulties acquiring proper healthcare. These findings may help in planning healthcare for Brazilian NF1 patients and improving their quality of life.

Entities:  

Keywords:  Disease knowledge; Genetic counseling; Healthcare; Neurofibromatosis 1; Psychosocial burden; Quality of life

Mesh:

Year:  2016        PMID: 26944915     DOI: 10.1007/s10897-016-9939-8

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  40 in total

1.  Religion, health, and psychological well-being in older adults: findings from three national surveys.

Authors:  J S Levin; L M Chatters
Journal:  J Aging Health       Date:  1998-11

2.  Visibility of neurofibromatosis 1 and psychiatric morbidity.

Authors:  Pierre Wolkenstein; Jacques Zeller; Jean Revuz; Emmanuel Ecosse; Alain Leplège
Journal:  Arch Dermatol       Date:  2003-01

3.  Data collection in clinical-qualitative research: use of non-directed interviews with open-ended questions by health professionals.

Authors:  Bruno José Barcellos Fontanella; Claudinei José Gomes Campos; Egberto Ribeiro Turato
Journal:  Rev Lat Am Enfermagem       Date:  2006 Sep-Oct

4.  Clinical and healthcare status of patients with neurofibromatosis type 1.

Authors:  A K Langenbruch; M Augustin; S Granström; L Kluwe; V F Mautner
Journal:  Br J Dermatol       Date:  2011-07       Impact factor: 9.302

Review 5.  National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987.

Authors: 
Journal:  Neurofibromatosis       Date:  1988

6.  A psychiatric 12-year follow-up of adult patients with neurofibromatosis type 1.

Authors:  M E Zöller; B Rembeck
Journal:  J Psychiatr Res       Date:  1999 Jan-Feb       Impact factor: 4.791

7.  Gender response to neurofibromatosis 1.

Authors:  J Ablon
Journal:  Soc Sci Med       Date:  1996-01       Impact factor: 4.634

8.  Spirituality in patients with advanced illness: The role of symptom control, resilience and social network.

Authors:  Miguel Fombuena; Laura Galiana; Pilar Barreto; Amparo Oliver; Antonio Pascual; Ana Soto-Rubio
Journal:  J Health Psychol       Date:  2015-05-28

9.  Young Australian adults with NF1 have poor access to health care, high complication rates, and limited disease knowledge.

Authors:  Emily C Oates; Jonathan M Payne; Sheryl L Foster; Nigel F Clarke; Kathryn N North
Journal:  Am J Med Genet A       Date:  2013-02-20       Impact factor: 2.802

10.  Neurofibromatosis type 1 (NF1): knowledge, experience, and reproductive decisions of affected patients and families.

Authors:  C M Benjamin; A Colley; D Donnai; H Kingston; R Harris; L Kerzin-Storrar
Journal:  J Med Genet       Date:  1993-07       Impact factor: 6.318

View more
  10 in total

1.  CRMP2-Neurofibromin Interface Drives NF1-related Pain.

Authors:  Aubin Moutal; Li Sun; Xiaofang Yang; Wennan Li; Song Cai; Shizhen Luo; Rajesh Khanna
Journal:  Neuroscience       Date:  2018-04-12       Impact factor: 3.590

2.  Health Survey of Adults with Neurofibromatosis 1 Compared to Population Study Controls.

Authors:  Krister W Fjermestad; Livø Nyhus; Øivind J Kanavin; Arvid Heiberg; Lise B Hoxmark
Journal:  J Genet Couns       Date:  2018-02-10       Impact factor: 2.537

3.  Social Function and Autism Spectrum Disorder in Children and Adults with Neurofibromatosis Type 1: a Systematic Review and Meta-Analysis.

Authors:  Anita K Chisholm; Vicki A Anderson; Natalie A Pride; Stephanie Malarbi; Kathryn N North; Jonathan M Payne
Journal:  Neuropsychol Rev       Date:  2018-08-11       Impact factor: 7.444

Review 4.  Towards a neurobiological understanding of pain in neurofibromatosis type 1: mechanisms and implications for treatment.

Authors:  Shreya S Bellampalli; Rajesh Khanna
Journal:  Pain       Date:  2019-05       Impact factor: 6.961

5.  The mediating effects of quality of life, depression, and generalized anxiety on perceived barriers to employment success for people diagnosed with Neurofibromatosis Type 1.

Authors:  Frank D Buono; Matthew E Sprong; Erina Paul; Staci Martin; Kaitlyn Larkin; Amir Garakani
Journal:  Orphanet J Rare Dis       Date:  2021-05-21       Impact factor: 4.123

6.  CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide.

Authors:  Aubin Moutal; Xiaofang Yang; Wennan Li; Kerry B Gilbraith; Shizhen Luo; Song Cai; Liberty François-Moutal; Lindsey A Chew; Seul Ki Yeon; Shreya S Bellampalli; Chaoling Qu; Jennifer Y Xie; Mohab M Ibrahim; May Khanna; Ki Duk Park; Frank Porreca; Rajesh Khanna
Journal:  Pain       Date:  2017-12       Impact factor: 7.926

7.  Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.

Authors:  Rosalie E Ferner; Mary Thomas; Gemma Mercer; Victoria Williams; Guy D Leschziner; Shazia K Afridi; John F Golding
Journal:  Health Qual Life Outcomes       Date:  2017-02-14       Impact factor: 3.186

Review 8.  Pain symptomology, functional impact, and treatment of people with Neurofibromatosis type 1.

Authors:  Frank D Buono; Lauretta E Grau; Matthew E Sprong; Kenneth L Morford; Kimberly J Johnson; David H Gutmann
Journal:  J Pain Res       Date:  2019-08-22       Impact factor: 3.133

9.  A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India.

Authors:  Aditi Mahajan; Milind Patvekar; Samruddhi Lote; Mahendra Singh Deora; Divya Poulose; Jaya Madhurya Gogineni; Krish Panikar; Biswajit Chaklader
Journal:  Cureus       Date:  2022-02-19

10.  A qualitative study of the impact of plexiform neurofibromas on need fulfilment in adults with neurofibromatosis type 1.

Authors:  Alice Heaney; Jeanette Wilburn; Shannon Langmead; Jaishri Blakeley; Susan Huson; Carly Jim; Stephen P McKenna
Journal:  SAGE Open Med       Date:  2019-02-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.